Back to
VANGUARD GROUP INC
CUE6 quarters
Position history for
VANGUARD GROUP INC's holdings in CUE BIOPHARMA INC
As of its last 13F, for Q4 2025, Vanguard Group held 3,014,034 shares of CUE (Cue Biopharma), worth $919,280. It reduced the position by 25,288 shares (-0.8%) from Q3 2025. Vanguard Group held CUE from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$919,280
Current Shares
3M
Total Value Change
-$618,506
Total Shares Change
+982,613
Quarter-by-Quarter History
Other major holders of CUE: Avoro Capital Advisors LLC, STATE STREET CORP